ESG

As it heads to key conferences, Orchestra BioMed is pitching its novel pacemaker-based hypertension treatment and a unique drug-eluting balloon.

The virtual care provider extends its specialized behavioral health services for Medicare patients to Arizona, Illinois, and Indiana amid a provider shortage.

Clene Inc. faces investors with promising data for ALS and MS, but a looming cash crunch makes its upcoming conference a critical test of survival.

An international team receives a major grant to use artificial intelligence to predict survival and treatment response, offering new hope for a deadly disease.

Princeton NuEnergy hires a battery industry titan to spearhead its commercial push, aiming to dominate the booming U.S. battery recycling market.

Reunion Neuroscience hits the investor conference circuit, seeking capital to advance its groundbreaking psychedelic-inspired therapies for depression and anxiety.

Canada's space pioneer MDA is moving into land, sea, and air defence with a new subsidiary, aiming to capture billions in spending and boost national security.

The sole Massachusetts surgery center to win a top national award for patient experience reveals the collaborative model behind its unprecedented success.

With new kits for complex cell models, Atrandi's semi-permeable capsules challenge market leaders by enabling multi-step workflows previously out of reach.

Fractal's new healthcare AI has surpassed leading models from OpenAI and Google, signaling a major leap for India's sovereign AI ambitions and public health.

The mobile health firm now reaches 25 states with its tech-driven model, aiming to close care gaps and answer federal critics of in-home assessments.

Five Alberta First Nations launch a legal challenge against a federal-provincial deal, citing a lack of consent for the world's largest proposed CCS project.

A new global study shows India leading in green energy commitment, while others lag. But the real challenge isn't just policy—it's a critical shortage of skills.

With a major €12.5M EU funding package, Step Pharma is fast-tracking dencatistat, a novel therapy targeting a key vulnerability in ovarian and endometrial cancers.

New data shows an AI-driven approach is enrolling IBD patients 3.4x faster, promising to accelerate the delivery of novel therapies to those in need.

Milliken's Borchers brand targets Asia's booming coatings market with tailored, eco-friendly additives and expanded technical support from its Pune hub.

An advocacy group challenges the University of Denver's animal-law program, demanding proof of impact and raising questions about donor funds.

A landmark partnership will deliver 70M gallons of sustainable aviation fuel, fueled by corporate demand for decarbonization and key government incentives.

Specialist asset manager Sprott Inc. leverages a volatile market and geopolitical tensions, riding a precious metals boom to record profits and AUM growth.

Early data on YOLT-202 shows it can safely restore normal protein levels in patients with Alpha-1 Antitrypsin Deficiency, a major step toward a cure.